In summary, our findings revealed that downregulation of MMP-2/MMP-9 induces the apoptosis and impairs the viability, migration, and invasion of RB tumor cells, providing a potential MMP target therapy in RB patients. The gene discussed is MMP2; the disease is neoplasm.